News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Raul Cordoba: Nivolumab-AVD vs Brentuximab Vedotin–AVD in Advanced-Stage Classic Hodgkin Lymphoma
Jun 18, 2025, 09:15

Raul Cordoba: Nivolumab-AVD vs Brentuximab Vedotin–AVD in Advanced-Stage Classic Hodgkin Lymphoma

Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA), shared a post on X:

“Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 |⁩ Journal of Clinical Oncology”

Title: Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826

Authors: Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael LeBlanc, Sairah Ahmed, Kelly Davison, Susan K. Parsons, Joseph M. Unger, Anamarija M. Perry, Carla Casulo, Nancy L. Bartlett, Joseph M. Tuscano, Brian T. Hess, Pallawi Torka, Pankaj Kumar, Ryan Jacobs, Joo Y. Song, Sharon M. Castellino, Brad Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M. Evens

Read Full Article.

Nivolumab-AVD Nivolumab-AVD

More posts featuring Raul Cordoba on OncoDaily

Alex F. Herrera Anamarija M. Perry Andrew M. Evens Brad Kahl Brentuximab Vedotin–AVD Brian T. Hess cancer Carla Casulo Hongli Li John P. Leonard Jonathan W. Friedberg Joo Y. Song Joseph M. Tuscano Joseph M. Unger Journal of Clinical Oncology Kelly Davison Michael LeBlanc Nancy L Bartlett Nivolumab-AVD OncoDaily Oncology Pallawi Torka Pankaj Kumar Raul Cordoba Ryan Jacobs Sairah Ahmed Sarah C. Rutherford Sharon M. Castellino Sonali M. Smith Susan K. Parsons
Special Coverage
Blog
Jul 8, 2025, 20:46
Experts Driving Innovation in Radiation Oncology Through the ESTRO Focus Group
Blog
Jul 8, 2025, 20:27
Abdu Adem Yesufe: Immensely Grateful for IAEA's Support Thus Far
Blog
Jul 8, 2025, 20:24
Svetlana Nikic: Honored to Attend HBA and Almirall Event on Women’s Development
Blog
Jul 8, 2025, 20:03
Alfredo Addeo: Colloquiums of the Department of Medicine in HUG Presented a Fascinating Conference
Blog
Jul 8, 2025, 19:47
A Webinar on "Overcoming Barriers to Pediatric Cancer Care in Nepal" on July 17 - The Max Foundation
Blog
Jul 8, 2025, 19:34
Edward Cliff: A Short Taster of Our Session to the Video Journal of Hematology and Hematological Oncology
Drugs
Jul 8, 2025, 18:55
Miguel Bronchud: Who Pays for New Drugs?
Blog
Jul 8, 2025, 18:45
Women With Overweight/Obesity and a History of CVD are 31% More Likely to Develop Breast Cancer - IARC
Blog
Jul 8, 2025, 18:08
A New Report on Ethnic Inequalities in Cancer Care - European Cancer Organisation
Blog
Jul 8, 2025, 18:00
Susanna Fletcher Greer: "Buck up." Considering a Career in Science?
Drugs
Jul 8, 2025, 17:57
Maria Babak: A Meaningful Step Forward for ROS1-Positive NSCLC
Blog
Jul 8, 2025, 17:48
Registration Is Open the International Lung Cancer Survivorship Conference - LUNGevity Foundation